Pravachol is a statin. All major medical organizations suggest considering drugs in the statin family - not just Pravachol - to reduce the chance of a first heart attack or stroke in adults at increased risk. FDA officially approved Pravachol to reduce the chance of dying from heart attacks or strokes, having a heart attack and having procedures to unblock arteries in heart or legs in people with high cholesterol without heart disease or a stroke. FDA also approved Pravachol to lower LDL "bad" cholesterol, raise HDL "good" cholesterol, and lower triglycerides in adults and children 8 years and older with abnormal cholesterol levels from a genetic condition.
The American Heart Association suggests people consider a statin if their chance of heart attack or stroke over the next 10 years is more than 5%, and to take one if the chance is 7.5% or more. You can calculate your risk at: http://tinyurl.com/pyv57ne.
Long track record means that new‚ unexpected side effects are unlikely. Pravachol was approved by FDA in 1991 to lower cholesterol and was approved for prevention of heart attack or stroke in 1996. Since Pravachol has now been used by large numbers of people over a long time‚ the emergence of important side effects is less likely than with new drugs.
Including people who have unexplained high liver inflammation blood tests
Pravachol may harm your unborn baby. If you become pregnant, stop taking Pravachol
Do not take: Controlled human studies show Pravachol harms baby and potential benefits do not outweigh potential harms (FDA Category X)
Do not breastfeed - Pravachol gets into breast milk and may harm baby